寶龍商業(09909.HK)向上海悅商增資5,000萬人幣
寶龍商業(09909.HK)公布,全資附屬上海嘉(糸尚)、深圳市騰訊產業創投、管理層股東、上海商悅及上海悅商訂立增資協議。上海嘉(糸尚)同意向上海悅商出資5,000萬元人民幣(下同);及深圳騰訊同意向上海悅商出資5,000萬元。增資完成後,上海嘉(糸尚)將擁有上海悅商約8.3%權益。
增資完成後,公司和深圳騰訊將通過上海悅商加速研發,公司將注入業務和經驗,深圳騰訊引入技術,打造一條存量資產管理、投資、消費者和商戶服務、超級智能化場景,為行業創造新的價值空間,推動進步。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.